PFA
GILD icon

Pure Financial Advisors’s Gilead Sciences GILD Stock Holding History

Pure Financial Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$982K Buy
7,775
+802
+12% +$106K 0.01% 252
2026
Q1 		$972K Buy
6,973
+691
+11% +$96.8K 0.01% 227
2025
Q4 		$771K Buy
6,282
+1,369
+28% +$166K 0.01% 249
2025
Q3 		$545K Buy
4,913
+273
+6% +$31K 0.01% 292
2025
Q2 		$514K Buy
4,640
+1,167
+34% +$124K 0.01% 290
2025
Q1 		$389K Buy
3,473
+927
+36% +$95.7K 0.01% 279
2024
Q4 		$235K Buy
+2,546
New +$229K 0.01% 313
2015
Q3 		– Sell
-1,900
Closed -$222K – 68
2015
Q2 		$222K Sell
1,900
-400
-17% -$43.7K 0.11% 63
2015
Q1 		$226K Buy
+2,300
New +$234K 0.08% 54

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pure Financial Advisors's GILD Position: Q2 2026 in Review

Pure Financial Advisors increased its Gilead Sciences (GILD) stake by 12% in Q2 2026, buying an estimated $106K and bringing the position to 7,775 shares worth $982K. The position accounts for 0.01% of the portfolio, ranked #252.

Pure Financial Advisors first reported a position in GILD in Q1 2015 and has held it in 9 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Pure Financial Advisors held 7,775 shares of Gilead Sciences worth $982K as of Q2 2026.
  • Pure Financial Advisors bought 802 Gilead Sciences shares in Q2 2026, an estimated $106K.
  • Gilead Sciences made up 0.01% of Pure Financial Advisors's portfolio in Q2 2026, its #252 holding.
  • Pure Financial Advisors first reported a position in Gilead Sciences in Q1 2015 and has held it in 9 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Pure Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.